Former Biolase (NSDQ:BIOL) CEO Federico Pignatelli isn’t ready to put down his dukes after dropping his seat on the company’s board of directors.
Oracle Partners
Biolase ex-CEO Pignatelli ditches the board
Ex-Biolase CEO isn’t giving up without a fight
CEO Pignatelli out after court-ordered shake-up at Biolase
Boston Scientific’s peripherals buy bad news for Cardiovascular Systems? | Medtech Wall Street news for the week of May 19, 2014
Activist investor Oracle revives proxy war at Biolase
Judge cuts Biolase board of directors | Medtech legal news for the week of Mar. 31, 2014
Biolase board of directors cut by DE judge | Medtech personnel moves for the week of Mar. 24, 2014
UPDATE: Court cuts Biolase board, marketing VP under fire
*Updated March 25, 2014 at 10 a.m. Eastern with comment from Biolase sales & marketing vice president Brian Jaffe.